Accutane (Isotretinoin) Muscle Preservation Strategies

What isotretinoin does to muscle

The Absorica label lists musculoskeletal symptoms, sometimes severe, including back pain, arthralgia, myalgia, neck and extremity pain, stiffness, tendonitis and rare reports of rhabdomyolysis [1]. Increased creatine phosphokinase is among the most common adverse reactions, at 5% or more [1]. The older-format Accutane label cites a trial in which about 16% of patients developed musculoskeletal symptoms including arthralgia [2]. A 2010 review of oral retinoid neuromuscular effects reports creatine phosphokinase elevations, occasionally up to 100 times normal, particularly in people undergoing vigorous physical exercise [4].

Is there a tested way to protect muscle?

The isotretinoin trials cited on this page report acne lesions and relapse, not lean mass, strength or muscle function [5][6].

What the isotretinoin dosing trials compared

Labeled regimen: 0.5 to 1 mg/kg/day in two divided doses for 15 to 20 weeks, and up to 2 mg/kg/day in adults with very severe disease; once-daily dosing is not recommended, and the label states no cumulative mg/kg target [1][2]. Strauss and colleagues randomized 150 patients to 0.1, 0.5 or 1.0 mg/kg/day; all three gave a highly significant response with no significant difference between them, though 42% of the 0.1 mg/kg/day group needed retreatment [6]. A 2026 single-centre, single-blind trial found no significant difference between cumulative 120 and 150 mg/kg in lesion counts or severity (all p>0.20), with 12-month relapse of 26.7% versus 32.3% (p=0.619) [5].

Training and protein data from people not taking isotretinoin

A 2018 meta-analysis of 49 randomized trials with 1,863 participants found protein supplementation raised fat-free mass by 0.30 kg and one-repetition-maximum strength by 2.49 kg, with no further fat-free-mass gains above about 1.62 g/kg/day [3]. A 2016 trial of 19 strength trainees found lean mass rose about 1 kg whether weekly volume was split across three sessions or one, with no significant difference between groups [7].

What the label asks for

The Absorica label requires a fasting lipid profile and liver function tests in all patients [1]. It also says to avoid supplements containing vitamin A, because isotretinoin is closely related to vitamin A and combined use may lead to isotretinoin-associated adverse reactions [1].